High Nucleotide Yeast Extract Market Size to Hit USD 3.03 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on High Nucleotide Yeast Extract Market

5.1. COVID-19 Landscape: High Nucleotide Yeast Extract Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global High Nucleotide Yeast Extract Market, By Nucleotide Content

8.1. High Nucleotide Yeast Extract Market Revenue and Volume, by Nucleotide Content

8.1.1. Standard nucleotide yeast extract

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Enriched high-nucleotide extract (>10% concentration)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Customized nucleotide blends

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global High Nucleotide Yeast Extract Market, By Source Yeast

9.1. High Nucleotide Yeast Extract Market Revenue and Volume, by Source Yeast

9.1.1. Saccharomyces cerevisiae (baker’s yeast)

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Brewer’s yeast

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Torula yeast

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Other yeast strains

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global High Nucleotide Yeast Extract Market, By Processing Method

10.1. High Nucleotide Yeast Extract Market Revenue and Volume, by Processing Method

10.1.1. Autolysis-derived extract

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Enzymatic hydrolysis extracts

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Thermal hydrolysis extracts

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global High Nucleotide Yeast Extract Market, By Application

11.1. High Nucleotide Yeast Extract Market Revenue and Volume, by Application

11.1.1. Food & beverages

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Nutraceuticals & dietary supplements

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Animal nutrition & feed additives

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Pharmaceuticals (nutrient fortification, excipients)

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global High Nucleotide Yeast Extract Market, By Form

12.1. High Nucleotide Yeast Extract Market Revenue and Volume, by Form

12.1.1. Powder

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Paste

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Liquid

12.1.3.1. Market Revenue and Volume Forecast

Chapter 13. Global High Nucleotide Yeast Extract Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.1.2. Market Revenue and Volume Forecast, by Source Yeast

13.1.3. Market Revenue and Volume Forecast, by Processing Method

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by Form

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.1.6.2. Market Revenue and Volume Forecast, by Source Yeast

13.1.6.3. Market Revenue and Volume Forecast, by Processing Method

13.1.6.4. Market Revenue and Volume Forecast, by Application

13.1.6.5. Market Revenue and Volume Forecast, by Form

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.1.7.2. Market Revenue and Volume Forecast, by Source Yeast

13.1.7.3. Market Revenue and Volume Forecast, by Processing Method

13.1.7.4. Market Revenue and Volume Forecast, by Application

13.1.7.5. Market Revenue and Volume Forecast, by Form

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.2.2. Market Revenue and Volume Forecast, by Source Yeast

13.2.3. Market Revenue and Volume Forecast, by Processing Method

13.2.4. Market Revenue and Volume Forecast, by Application

13.2.5. Market Revenue and Volume Forecast, by Form

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.2.6.2. Market Revenue and Volume Forecast, by Source Yeast

13.2.6.3. Market Revenue and Volume Forecast, by Processing Method

13.2.7. Market Revenue and Volume Forecast, by Application

13.2.8. Market Revenue and Volume Forecast, by Form

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.2.9.2. Market Revenue and Volume Forecast, by Source Yeast

13.2.9.3. Market Revenue and Volume Forecast, by Processing Method

13.2.10. Market Revenue and Volume Forecast, by Application

13.2.11. Market Revenue and Volume Forecast, by Form

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.2.12.2. Market Revenue and Volume Forecast, by Source Yeast

13.2.12.3. Market Revenue and Volume Forecast, by Processing Method

13.2.12.4. Market Revenue and Volume Forecast, by Application

13.2.13. Market Revenue and Volume Forecast, by Form

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.2.14.2. Market Revenue and Volume Forecast, by Source Yeast

13.2.14.3. Market Revenue and Volume Forecast, by Processing Method

13.2.14.4. Market Revenue and Volume Forecast, by Application

13.2.15. Market Revenue and Volume Forecast, by Form

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.3.2. Market Revenue and Volume Forecast, by Source Yeast

13.3.3. Market Revenue and Volume Forecast, by Processing Method

13.3.4. Market Revenue and Volume Forecast, by Application

13.3.5. Market Revenue and Volume Forecast, by Form

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.3.6.2. Market Revenue and Volume Forecast, by Source Yeast

13.3.6.3. Market Revenue and Volume Forecast, by Processing Method

13.3.6.4. Market Revenue and Volume Forecast, by Application

13.3.7. Market Revenue and Volume Forecast, by Form

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.3.8.2. Market Revenue and Volume Forecast, by Source Yeast

13.3.8.3. Market Revenue and Volume Forecast, by Processing Method

13.3.8.4. Market Revenue and Volume Forecast, by Application

13.3.9. Market Revenue and Volume Forecast, by Form

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.3.10.2. Market Revenue and Volume Forecast, by Source Yeast

13.3.10.3. Market Revenue and Volume Forecast, by Processing Method

13.3.10.4. Market Revenue and Volume Forecast, by Application

13.3.10.5. Market Revenue and Volume Forecast, by Form

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.3.11.2. Market Revenue and Volume Forecast, by Source Yeast

13.3.11.3. Market Revenue and Volume Forecast, by Processing Method

13.3.11.4. Market Revenue and Volume Forecast, by Application

13.3.11.5. Market Revenue and Volume Forecast, by Form

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.4.2. Market Revenue and Volume Forecast, by Source Yeast

13.4.3. Market Revenue and Volume Forecast, by Processing Method

13.4.4. Market Revenue and Volume Forecast, by Application

13.4.5. Market Revenue and Volume Forecast, by Form

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.4.6.2. Market Revenue and Volume Forecast, by Source Yeast

13.4.6.3. Market Revenue and Volume Forecast, by Processing Method

13.4.6.4. Market Revenue and Volume Forecast, by Application

13.4.7. Market Revenue and Volume Forecast, by Form

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.4.8.2. Market Revenue and Volume Forecast, by Source Yeast

13.4.8.3. Market Revenue and Volume Forecast, by Processing Method

13.4.8.4. Market Revenue and Volume Forecast, by Application

13.4.9. Market Revenue and Volume Forecast, by Form

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.4.10.2. Market Revenue and Volume Forecast, by Source Yeast

13.4.10.3. Market Revenue and Volume Forecast, by Processing Method

13.4.10.4. Market Revenue and Volume Forecast, by Application

13.4.10.5. Market Revenue and Volume Forecast, by Form

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.4.11.2. Market Revenue and Volume Forecast, by Source Yeast

13.4.11.3. Market Revenue and Volume Forecast, by Processing Method

13.4.11.4. Market Revenue and Volume Forecast, by Application

13.4.11.5. Market Revenue and Volume Forecast, by Form

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.5.2. Market Revenue and Volume Forecast, by Source Yeast

13.5.3. Market Revenue and Volume Forecast, by Processing Method

13.5.4. Market Revenue and Volume Forecast, by Application

13.5.5. Market Revenue and Volume Forecast, by Form

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.5.6.2. Market Revenue and Volume Forecast, by Source Yeast

13.5.6.3. Market Revenue and Volume Forecast, by Processing Method

13.5.6.4. Market Revenue and Volume Forecast, by Application

13.5.7. Market Revenue and Volume Forecast, by Form

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Nucleotide Content

13.5.8.2. Market Revenue and Volume Forecast, by Source Yeast

13.5.8.3. Market Revenue and Volume Forecast, by Processing Method

13.5.8.4. Market Revenue and Volume Forecast, by Application

13.5.8.5. Market Revenue and Volume Forecast, by Form

Chapter 14. Company Profiles

14.1. Angel Yeast Co., Ltd.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Lesaffre Group

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. DSM-Firmenich

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Ohly GmbH (Associated British Foods)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Kerry Group plc

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Lallemand Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Biospringer (part of Lesaffre)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Biorigin

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Zhejiang Silver-Elephant Bio-Engineering Co., Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Shandong Sunkeen Biotechnology Co., Ltd.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The high nucleotide yeast extract market size is expected to increase from USD 1.25 billion in 2024 to USD 3.03 billion by 2034.

The high nucleotide yeast extract market is expected to grow at a compound annual growth rate (CAGR) of around 9.24% from 2025 to 2034.

The major players in the high nucleotide yeast extract market include Angel Yeast Co., Ltd., Lesaffre Group, DSM-Firmenich, Ohly GmbH (Associated British Foods), Kerry Group plc, Lallemand Inc., Biospringer (part of Lesaffre), Biorigin, Zhejiang Silver-Elephant Bio-Engineering Co., Ltd., Shandong Sunkeen Biotechnology Co., Ltd., ABF Ingredients, Synergy Flavors (yeast-based extracts), Sensient Technologies Corporation, KOHJIN Life Sciences Co., Ltd., Thai Foods International PCL (TFI), Mitushi Biopharma, Thai Fermentation Industry Co., Ltd., Aohata Corporation (specialty ingredients), Savoury Systems International LLC, and Zhuhai Txaky Biotech Co., Ltd.

The driving factors of the high nucleotide yeast extract market are the increasing demand for natural flavor enhancers and clean-label food ingredients in processed foods

Asia Pacific region will lead the global high nucleotide yeast extract market during the forecast period 2025 to 2034.